Chronic eosinophilic leukemia – Not otherwise specified with literature review
Journal Title: International Journal of Allied Medical Sciences and Clinical Research - Year 2017, Vol 5, Issue 1
Abstract
Chronic eosinophilic leukemia not otherwise specified (CEL NOS) is a rare disorder with hypereosinophilia and an increased number of blood or bone marrow blasts (<20%) or an evidence of eosinophilic clonality. It constitutes a new entity in the 2008 revised World Health Organization classification (WHO). We report a case of CEL NOS in an 18 year old male who presented with extensive thromboembolism.
Authors and Affiliations
Sohaila Fatima
Keywords
Related Articles
- EP ID EP418245
- DOI -
- Views 64
- Downloads 0
Unusual incidental findings of routine histopathological examination of appendectomy specimens- a 2-year retrospective analysis with review of the literature
Objective To review the diagnosis of all patients that underwent appendectomy at our institute over a period of 2 years, and to correlate the histopathological diagnosis with the clinical diagnosis in each case. Material...
Power tools for inciting critical thinking among new research students
.
Added effect of cyriax deep friction massage on functional ability in patients with chronic plantar fasciitis
Objectives To assess the added effect of Cyriax deep friction massage along with conventional treatment on functional ability in patients with chronic plantar fasciitis. Methods In this experimental study, 26 subjects wi...
A study of maternal and fetal outcome in postdated pregnancy
Objective To assess the whether the elective induction of labor at 41 weeks is associated with lower caesarean section rates as compared to elective induction of labor at 40 weeks in a postdated pregnancy. Perinatal morb...
Effect of Butler’s sciatic nerve mobilisatision in low back pain patients with sciatica
Lumbar-spine disorders rank fifth among disease categories and the health care. Intervention in patients with a disease requires that the intervention has to be more beneficial, safer, and cost-effective. This dilemma is...